2023

Sharma, V., Ricketts, H. C., McCombie, L., Brosnahan, N. , Crawford, L., Slaughter, L., Goodfellow, A., Lean, M. E.J. and Cowan, D. C. (2023) A total diet replacement weight management programme for difficult-to-treat asthma associated with obesity: a randomised controlled feasibility trial. Chest, 163(5), pp. 1026-1037. (doi: 10.1016/j.chest.2023.01.015) (PMID:36649753)

Ricketts, H. C., Buchan, D. S., Steffensen, F., Chaudhuri, R. , Baker, J. S. and Cowan, D. C. (2023) Physical activity levels in asthma: relationship with disease severity, body mass index and novel accelerometer-derived metrics. Journal of Asthma, 60(4), pp. 824-834. (doi: 10.1080/02770903.2022.2102037) (PMID:35876843)

Sharma, V., Ricketts, H. C., Steffensen, F., Goodfellow, A. and Cowan, D. C. (2023) Obesity affects type 2 biomarker levels in asthma. Journal of Asthma, 60(2), pp. 385-392. (doi: 10.1080/02770903.2022.2051548) (PMID:35260034)

2022

Diver, S. et al. (2022) Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation. Allergy, 77(11), pp. 3362-3376. (doi: 10.1111/all.15425) (PMID:35778780)

Ricketts, H. C., Sharma, V., Steffensen, F., Goodfellow, A., Mackay, E., MacDonald, G., Buchan, D. S., Chaudhuri, R. and Cowan, D. C. (2022) A pragmatic randomised controlled trial of tailored pulmonary rehabilitation in participants with difficult-to-control asthma and elevated body mass index. BMC Pulmonary Medicine, 22, 363. (doi: 10.1186/s12890-022-02152-2) (PMID:36153525) (PMCID:PMC9509551)

McDowell, P. J. et al. (2022) Exacerbation profile and risk factors in a type-2–low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes. American Journal of Respiratory and Critical Care Medicine, 206(5), pp. 545-553. (doi: 10.1164/rccm.202201-0129OC) (PMID:35549845)

Busby, J. et al. (2022) Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma. European Respiratory Journal, 59, 2100768. (doi: 10.1183/13993003.00768-2021) (PMID:34561291) (PMCID:PMC9202483)

2021

Sharma, V. and Cowan, D. C. (2021) Obesity, inflammation, and severe asthma: an update. Current Allergy and Asthma Reports, 21(12), 46. (doi: 10.1007/s11882-021-01024-9)

Heaney, L. G. et al. (2021) Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Lancet Respiratory Medicine, 9(1), pp. 57-68. (doi: 10.1016/s2213-2600(20)30397-0) (PMID:32916135) (PMCID:PMC7783382)

2018

Hanratty, C. E. et al. (2018) A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial. Trials, 19, 5. (doi: 10.1186/s13063-017-2384-7) (PMID:29301585) (PMCID:PMC5753571)

2016

Chaudhuri, R. et al. (2016) Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma. Respiratory Medicine, 118, pp. 46-52. (doi: 10.1016/j.rmed.2016.07.005) (PMID:27578470)

2015

Bicknell, S. et al. (2015) Effectiveness of bronchial thermoplasty in severe asthma in ‘real life’ patients compared with those recruited to clinical trials in the same centre. Therapeutic Advances in Respiratory Disease, 9(6), pp. 267-271. (doi: 10.1177/1753465815601332) (PMID:26307767)

Articles

Sharma, V., Ricketts, H. C., McCombie, L., Brosnahan, N. , Crawford, L., Slaughter, L., Goodfellow, A., Lean, M. E.J. and Cowan, D. C. (2023) A total diet replacement weight management programme for difficult-to-treat asthma associated with obesity: a randomised controlled feasibility trial. Chest, 163(5), pp. 1026-1037. (doi: 10.1016/j.chest.2023.01.015) (PMID:36649753)

Ricketts, H. C., Buchan, D. S., Steffensen, F., Chaudhuri, R. , Baker, J. S. and Cowan, D. C. (2023) Physical activity levels in asthma: relationship with disease severity, body mass index and novel accelerometer-derived metrics. Journal of Asthma, 60(4), pp. 824-834. (doi: 10.1080/02770903.2022.2102037) (PMID:35876843)

Sharma, V., Ricketts, H. C., Steffensen, F., Goodfellow, A. and Cowan, D. C. (2023) Obesity affects type 2 biomarker levels in asthma. Journal of Asthma, 60(2), pp. 385-392. (doi: 10.1080/02770903.2022.2051548) (PMID:35260034)

Diver, S. et al. (2022) Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation. Allergy, 77(11), pp. 3362-3376. (doi: 10.1111/all.15425) (PMID:35778780)

Ricketts, H. C., Sharma, V., Steffensen, F., Goodfellow, A., Mackay, E., MacDonald, G., Buchan, D. S., Chaudhuri, R. and Cowan, D. C. (2022) A pragmatic randomised controlled trial of tailored pulmonary rehabilitation in participants with difficult-to-control asthma and elevated body mass index. BMC Pulmonary Medicine, 22, 363. (doi: 10.1186/s12890-022-02152-2) (PMID:36153525) (PMCID:PMC9509551)

McDowell, P. J. et al. (2022) Exacerbation profile and risk factors in a type-2–low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes. American Journal of Respiratory and Critical Care Medicine, 206(5), pp. 545-553. (doi: 10.1164/rccm.202201-0129OC) (PMID:35549845)

Busby, J. et al. (2022) Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma. European Respiratory Journal, 59, 2100768. (doi: 10.1183/13993003.00768-2021) (PMID:34561291) (PMCID:PMC9202483)

Sharma, V. and Cowan, D. C. (2021) Obesity, inflammation, and severe asthma: an update. Current Allergy and Asthma Reports, 21(12), 46. (doi: 10.1007/s11882-021-01024-9)

Heaney, L. G. et al. (2021) Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Lancet Respiratory Medicine, 9(1), pp. 57-68. (doi: 10.1016/s2213-2600(20)30397-0) (PMID:32916135) (PMCID:PMC7783382)

Hanratty, C. E. et al. (2018) A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial. Trials, 19, 5. (doi: 10.1186/s13063-017-2384-7) (PMID:29301585) (PMCID:PMC5753571)

Chaudhuri, R. et al. (2016) Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma. Respiratory Medicine, 118, pp. 46-52. (doi: 10.1016/j.rmed.2016.07.005) (PMID:27578470)

Bicknell, S. et al. (2015) Effectiveness of bronchial thermoplasty in severe asthma in ‘real life’ patients compared with those recruited to clinical trials in the same centre. Therapeutic Advances in Respiratory Disease, 9(6), pp. 267-271. (doi: 10.1177/1753465815601332) (PMID:26307767)